Smoking and Diabetes Control in Adults With Type 1 and Type 2 Diabetes: A Nationwide Study From the 2018 National Program for Prevention and Control of Diabetes of Iran

被引:18
|
作者
Molla, Ghasem Janbabaei [1 ]
Ismail-Beigi, Faramarz [2 ]
Larijani, Bagher [3 ]
Khaloo, Pegah [4 ]
Moosaie, Fatemeh [4 ]
Alemi, Hamid [4 ]
Mansournia, Mohammad Ali [5 ]
Ghadimi, Tayyeb [6 ]
Ghaemi, Fatemeh [7 ]
Nakhjavani, Manouchehr [4 ]
Esteghamati, Alireza [4 ]
机构
[1] Minist Hlth & Med Educ, Curat Affairs, Tehran, Iran
[2] Case Western Reserve Univ, Dept Med Biochem Physiol & Biophys, Div Clin & Mol Endocrinol, Cleveland, OH 44106 USA
[3] Univ Tehran Med Sci, Diabet Researcher Ctr, Endocrinol & Metab Res Inst, Tehran, Iran
[4] Univ Tehran Med Sci, Vali Asr Hosp, Endocrinol & Metab Res Ctr, Sch Med, Tehran, Iran
[5] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran
[6] Iran Med Univ, Dept Surg, Tehran, Iran
[7] Minist Hlth & Med Educ, Dept Transplantat & Dis, Tehran, Iran
关键词
cardiovascular diseases (CVD); diabetes complications; diabetes nephropathies; diabetes retinopathy; glycemic/lipid control; smoking; CIGARETTE-SMOKING; RISK-FACTORS; PROGRESSION; NEUROPATHY; MORTALITY; MELLITUS; DISEASE;
D O I
10.1016/j.jcjd.2019.07.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Smoking is among the top leading causes of morbidity and mortality worldwide. To date, studies on the association between smoking and diabetes complications and metabolic control have shown conflicting results. In this study, we aimed to assess the association of smoking with micro- and macrovascular complications of diabetes and lipid and glycemic indices. Methods: We used the National Program for Prevention and Control of Diabetes of Iran database of 99,651 adult patients with diabetes across Iran. Multiple logistic regression models were used to examine the association between smoking and diabetes complications including cardiovascular disease, neuropathy, nephropathy and retinopathy. This association was adjusted for age, sex, duration of diabetes, glycated hemoglobin (A1C), hypertension, hyperlipidemia, medication, obesity and type of diabetes. Results: Smoking was associated with cardiovascular disease, nephropathy, retinopathy and neuropathy (odds ratios [ORs1 for patients with type 1 diabetes were 1.51, 2.29, 2.70 and 2.40, respectively; for patients with type 2 diabetes, ORs were 1.27, 1.21, 1.51 and 1.70, respectively; all with p values <0.001). Among patients with type 1 diabetes, smoking was significantly (p<0.05) associated with A1C (OR, 2.12), 2-h postglucose level (OR, 1.30), triglycerides (OR, 1.48) and high-density lipoprotein (HDL) control (OR, 1.34). Among patients with type 2 diabetes, smoking was significantly associated with A1C (OR, 1.09) and HDL control (OR, 1.21). Conclusions: Smoking was associated with multiple diabetes complications including cardiovascular disease, neuropathy, nephropathy and retinopathy and worse A1C and HDL control in both patients with type 1 and type 2 diabetes. It was also associated with worse 2-h postglucose level and triglyceride control among patients with type 1 diabetes. Our findings signify that national programs for smoking prevention and cessation may be beneficial to diabetes control in Iran. (C) 2019 Canadian Diabetes Association.
引用
收藏
页码:246 / 252
页数:7
相关论文
共 50 条
  • [1] The Challenges of Iran's Type 2 Diabetes Prevention and Control Program
    Valizadeh, Reza
    Vali, Leila
    Bahaadinbeigy, Kambiz
    Amiresmaili, Mohammadreza
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2019, 10
  • [2] Determinants of glycemic control: Phase 2 analysis from nationwide diabetes report of National Program for Prevention and Control of Diabetes (NPPCD-2018)
    Esteghamati, Alireza
    Ismail-Beigi, Faramarz
    Khaloo, Pegah
    Moosaie, Fatemeh
    Alemi, Hamid
    Mansournia, Mohammad Ali
    Afarideh, Mohsen
    Molla, Ghasem Janbabaei
    Ghadimi, Teyyeb
    Shadnoush, Mehdi
    Kermanchi, Jamshid
    Ghaemi, Fatemeh
    PRIMARY CARE DIABETES, 2020, 14 (03) : 222 - 231
  • [3] Diabetes in Iran: Prospective Analysis from First Nationwide Diabetes Report of National Program for Prevention and Control of Diabetes (NPPCD-2016)
    Alireza Esteghamati
    Bagher Larijani
    Mohammad Haji Aghajani
    Fatemeh Ghaemi
    Jamshid Kermanchi
    Ali Shahrami
    Mohammad Saadat
    Ensieh Nasli Esfahani
    Morsaleh Ganji
    Sina Noshad
    Elias Khajeh
    Alireza Ghajar
    Behnam Heidari
    Mohsen Afarideh
    Jeffrey I. Mechanick
    Faramarz Ismail-Beigi
    Scientific Reports, 7
  • [4] Diabetes in Iran: Prospective Analysis from First Nationwide Diabetes Report of National Program for Prevention and Control of Diabetes (NPPCD-2016)
    Esteghamati, Alireza
    Larijani, Bagher
    Aghajani, Mohammad Haji
    Ghaemi, Fatemeh
    Kermanchi, Jamshid
    Shahrami, Ali
    Saadat, Mohammad
    Esfahani, Ensieh Nasli
    Ganji, Morsaleh
    Noshad, Sina
    Khajeh, Elias
    Ghajar, Alireza
    Heidari, Behnam
    Afarideh, Mohsen
    Mechanick, Jeffrey I.
    Ismail-Beigi, Faramarz
    SCIENTIFIC REPORTS, 2017, 7
  • [5] Evaluation of the effects of the national diabetes control and prevention program on a sample of iranian people with type 2 diabetes
    Haghravan, Simin
    Mohammadi-Nasrabadi, Fatemeh
    Rafraf, Maryam
    Jafarabadi, Mohammad Asghari
    MEDITERRANEAN JOURNAL OF NUTRITION AND METABOLISM, 2022, 15 (02) : 239 - 251
  • [6] The diabetes prevention and control program of Iran.
    Azizi, F
    Gouya, MM
    DIABETOLOGIA, 2003, 46 : A102 - A102
  • [8] Metformin for Prevention of Type 2 Diabetes - New Results from the Diabetes Prevention Program Study
    Fries, Charlotte
    DIABETOLOGE, 2019, 15 (04): : 344 - 345
  • [9] Diabetes Glycemic Control in Adults With Type 2 Diabetes Mellitus and ADHD
    Leshno, Dahlia
    Shalem, Liat Lev
    Gavze, Revital Perlove
    Leshno, Moshe
    JOURNAL OF ATTENTION DISORDERS, 2025, 29 (02) : 101 - 106
  • [10] Smoking and Metabolic Control in Adolescents with Type 1 Diabetes
    Hofer, Sabine E.
    Rosenbauer, Joachim
    Grulich-Henn, Juergen
    Naeke, Andrea
    Froehlich-Reiterer, Eilke
    Holl, Reinhard W.
    JOURNAL OF PEDIATRICS, 2009, 154 (01): : 20 - 23